Gil Ben-Horin
Published: Mar 16, 2008

Between November 2005 and June 2006, 1340, 2715, and 1035 patients were included in the control, DS and post-DS periods, respectively. During the control period, 38% of all high-risk patients were prescribed PONV prophylaxis. This increased to 73% during the DS period and decreased to 37% in the post-DS period.

Back to lobby

Sign up for the latest updates

© 2024 iMDsoft. All rights reserved.